Who’s Who: Ahmed Eisa Abu Amara, chief legal council at Saudi Arabia’s Council of Cooperative Health Insurance

Ahmed Eisa Abu Amara
Short Url
Updated 05 August 2021
Follow

Who’s Who: Ahmed Eisa Abu Amara, chief legal council at Saudi Arabia’s Council of Cooperative Health Insurance

Ahmed Eisa Abu Amara has served as chief legal council at the Council of Cooperative Health Insurance since 2019.

In early 2019, he became general director of the General Department of Legal Affairs at the Ministry of Human Resources and Social Development. In 2016, he became head of legal affairs for the Saudi Arabian Olympic Committee.

From 2007 to 2013, he worked as a senior legal consultant and senior insurance supervisor at the Saudi Central Bank (SAMA).

Since 2018, Amara has been an international arbitrator at the International Council of Arbitration in Lausanne, Switzerland. Also in 2018, he served as an associate lecturer in commercial law at Majmaah University.  

He is currently an arbitrator at the National Sports Arbitration Tribunal in Kuwait and at the Saudi Arbitration Center in Riyadh since 2020.

In January 2015, he was appointed honorary commissioner at the Louisiana Department of Insurance by Commissioner Jim Donelon.

In 2011, he received his master’s degree in law from the Southern Methodist University in Dallas, Texas. He also received a bachelor’s degree in law from King Saud University in Riyadh.

Amara has acquired several diplomas in various fields, including a diploma in the management of Olympic sports institutions from the International Olympic Academy; an international insurance and reinsurance diploma from the Chartered Insurance Institute and Lloyd’s Market Association in London; and a diploma in real estate from Richland College, Texas.

In 2018, he enrolled in the Professional Development Program at Harvard University, studying courses on management and leadership.


Saudi hospital pioneers preventive type 1 diabetes treatment

KFSH&RC has introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes. (SPA)
Updated 59 min 11 sec ago
Follow

Saudi hospital pioneers preventive type 1 diabetes treatment

  • The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease

RIYADH: King Faisal Specialist Hospital and Research Center introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes, the Saudi Press Agency reported on Wednesday.
The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease. It marks the first time such a treatment has been implemented in the Kingdom.
The initial application involved two patients who met all the criteria outlined in the approved protocol. The step represents a major advance in early preventive care for one of the most common autoimmune conditions affecting children and adolescents.
Both cases were treated at the hospital’s Department of Pediatrics. For families already managing type 1 diabetes, the innovation brings new hope.
Siblings of affected children often face increased risk due to shared genetic and immune factors. Preventive options like this could significantly lower those risks in the future.
The treatment targets the early, pre-type 1 diabetes stage when insulin-producing pancreatic cells begin to deteriorate. Through early intervention, doctors can slow this damage, delay the onset of symptoms and help extend the time before full disease progression.
Implementing the therapy required careful preparation. The drug was compounded in the hospital pharmacy under a precise protocol, while nursing teams received training on administration, monitoring and managing possible reactions.
Medical staff were also briefed on patient selection and follow-up criteria based on the latest clinical guidelines.
According to the SPA, experts expect the program to inspire national research focused on the early stages of the disease and on developing preventive approaches that enhance quality of life for at-risk groups.
KFSH&RC continues to gain recognition on the global stage. It was ranked first in the Middle East and Africa, and 15th worldwide among the top 250 academic medical centers for 2025.
The hospital was also named the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance 2025.
Additionally, Newsweek included KFSH&RC on its lists of the World’s Best Hospitals (2025), the World’s Smartest Hospitals (2026) and the World’s Best Specialized Hospitals (2026).